95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS

Overview of attention for article published in Journal of Hepatology, April 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 12 patents

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 12 patents that reference this research output.

SANGLIFEHRIN DERIVATIVES AND METHODS FOR THEIR PRODUCTION

Application EP-3427737-A1

European Patent Office

16 Jan 2019

MACROCYCLIC COMPOUND AND METHODS FOR ITS PRODUCTION

Application KR-20140057481-A

Republic of Korea

13 May 2014

Treatment of hepatitis c virus infection with alisporivir

Application CN-103648516-A

China

19 Mar 2014

NOVEL DOSAGE FORM

Application WO-2013061052-A1

World Intellectual Property Organisation (WIPO)

02 May 2013

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.